BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Tag: Enteroendocrine cell › mRNA and microRNA profile in colon cancer [mRNA data]

Dataset: mRNA and microRNA profile in colon cancer [mRNA data]

Compariosn of mRNA and miRNA profile in colon cancer mRNA was extracted from colon tissues for microarray analysis

Registered by ArrayExpress Uploader
View Dataset

Compariosn of mRNA and miRNA profile in colon cancer mRNA was extracted from colon tissues for microarray analysis

Species:
human

Samples:
65

Source:
E-GEOD-29621

Updated:
Dec.12, 2014

Registered:
Jul.11, 2014


Factors: (via ArrayExpress)
Sample T STAGE CORRESPONDING TO GSE17536 ADJUVANT CHEMO M STAGE 0 N STAGE OVERALL SURVIVAL OS HISTOLOGIC GRADE AJCC STAGING DISEASE-FREE SURVIVAL TIME DFS OS EVENT SEX DFS EVENT
GSM734175 3 GSM437176 Y no; 1: metastasis): 0 2 11.76 MOD DIFF Stage 3 8.21 dead male recurrence
GSM734174 3 GSM437210 Y no; 1: metastasis): 0 1 54.54 MOD DIFF Stage 3 26.92 alive female no recurrence
GSM734173 3 GSM437237 Y no; 1: metastasis): 1 0 15.28 MOD DIFF Stage 4 NA dead male NA
GSM734172 3 GSM437158 Y no; 1: metastasis): 0 0 49.87 MOD DIFF Stage 2 36.75 alive female no recurrence
GSM73417 4 GSM437129 Y no; 1: metastasis): 0 0 102.44 MOD DIFF Stage 2 64.86 alive male no recurrence
GSM734170 3 GSM437148 N no; 1: metastasis): 0 0 52.14 MOD DIFF Stage 2 52.14 alive female no recurrence
GSM734169 3 GSM437208 N no; 1: metastasis): 0 1 58.45 MOD DIFF Stage 3 58.45 alive female no recurrence
GSM734168 3 GSM437185 Y no; 1: metastasis): 0 1 99.51 WELL DIFF Stage 3 99.51 alive female no recurrence
GSM734167 2 GSM437114 N no; 1: metastasis): 0 0 3.64 MOD DIFF Stage 1 3.64 alive male no recurrence
GSM734166 2 GSM437097 Y no; 1: metastasis): 0 0 59.53 MOD DIFF Stage 1 59.53 alive male no recurrence
GSM734165 2 GSM437101 N no; 1: metastasis): 0 0 65.88 MOD DIFF Stage 1 65.88 dead male no recurrence
GSM734164 2 GSM437115 N no; 1: metastasis): 0 0 36.59 WELL DIFF Stage 1 23.96 alive male no recurrence
GSM734163 2 GSM437109 N no; 1: metastasis): 0 0 55.13 MOD DIFF Stage 1 55.13 alive female no recurrence
GSM734162 2 GSM437106 N no; 1: metastasis): 0 0 67.82 MOD DIFF Stage 1 67.82 alive female no recurrence
GSM73416 2 GSM437107 N no; 1: metastasis): 0 0 52.24 WELL DIFF Stage 1 52.24 alive male no recurrence
GSM734160 3 GSM437173 N no; 1: metastasis): 0 0 27.15 MOD DIFF Stage 2 27.15 dead female no recurrence
GSM734159 3 GSM437170 N no; 1: metastasis): 0 0 15.05 MOD DIFF Stage 2 15.05 alive male no recurrence
GSM734158 3 GSM437169 Y no; 1: metastasis): 0 0 83.99 MOD DIFF Stage 2 22.38 alive female recurrence
GSM734157 3 GSM437162 N no; 1: metastasis): 0 0 26.66 MOD DIFF Stage 2 26.66 alive male no recurrence
GSM734156 3 GSM437161 N no; 1: metastasis): 0 0 35.9 MOD DIFF Stage 2 35.9 alive male no recurrence
GSM734155 3 GSM437160 N no; 1: metastasis): 0 0 44.97 MOD DIFF Stage 2 44.97 alive male no recurrence
GSM734154 3 GSM437159 N no; 1: metastasis): 0 0 25.24 MOD DIFF Stage 2 25.24 alive male no recurrence
GSM734153 4 GSM437121 Y no; 1: metastasis): 0 0 120.62 MOD DIFF Stage 2 27.64 alive female recurrence
GSM734152 3 GSM437155 Y no; 1: metastasis): 0 0 37.67 MOD DIFF Stage 2 17.95 alive female no recurrence
GSM73415 3 GSM437152 Y no; 1: metastasis): 0 0 58.45 MOD DIFF Stage 2 46.71 alive female no recurrence
GSM734150 3 GSM437150 N no; 1: metastasis): 0 0 59.96 WELL DIFF Stage 2 59.96 alive male no recurrence
GSM734149 3 GSM437147 N no; 1: metastasis): 0 0 34.09 POORLY DIFF Stage 2 24.19 alive female no recurrence
GSM734148 4 NA N no; 1: metastasis): X X 61.57 POORLY DIFF Stage 2 61.57 alive female no recurrence
GSM734147 3 GSM437146 Y no; 1: metastasis): 0 0 63.25 MOD DIFF Stage 2 63.25 alive male no recurrence
GSM734146 3 GSM437144 N no; 1: metastasis): 0 0 37.31 MOD DIFF Stage 2 37.31 dead male no recurrence
GSM734145 3 GSM437118 N no; 1: metastasis): 0 0 55.33 POORLY DIFF Stage 2 55.33 alive female no recurrence
GSM734144 3 GSM437128 Y no; 1: metastasis): 0 0 88.99 MOD DIFF Stage 2 88.99 alive male no recurrence
GSM734143 3 GSM437126 N no; 1: metastasis): 0 0 52.5 MOD DIFF Stage 2 52.5 dead female no recurrence
GSM734142 3 GSM437269 Y no; 1: metastasis): 1 0 22.35 MOD DIFF Stage 4 NA alive male NA
GSM73414 4 GSM437264 N no; 1: metastasis): 1 0 9.96 MOD DIFF Stage 4 9.96 dead female no recurrence
GSM734140 3 GSM437263 Y no; 1: metastasis): 1 1 14.56 MOD DIFF Stage 4 NA dead male NA
GSM734139 3 GSM437262 N no; 1: metastasis): 1 1 15.25 MOD DIFF Stage 4 NA dead male NA
GSM734138 3 GSM437255 Y no; 1: metastasis): 1 1 60.75 MOD DIFF Stage 4 55.19 alive female no recurrence
GSM734137 3 GSM437259 Y no; 1: metastasis): 1 1 31.85 MOD DIFF Stage 4 NA alive male NA
GSM734136 3 GSM437253 Y no; 1: metastasis): 1 1 1.44 POORLY DIFF Stage 4 NA dead male NA
GSM734135 3 GSM437252 Y no; 1: metastasis): 1 2 34.02 MOD DIFF Stage 4 NA dead female NA
GSM734134 3 GSM437231 Y no; 1: metastasis): 1 1 18.54 MOD DIFF Stage 4 NA dead male NA
GSM734133 3 GSM437240 Y no; 1: metastasis): 1 2 28.89 MOD DIFF Stage 4 NA dead male NA
GSM734132 3 GSM437238 Y no; 1: metastasis): 1 1 95.07 MOD DIFF Stage 4 82.61 alive male no recurrence
GSM73413 3 GSM437236 Y no; 1: metastasis): 1 1 5.72 MOD DIFF Stage 4 NA dead male NA
GSM734130 3 GSM437239 N no; 1: metastasis): 1 1 4.96 MOD DIFF Stage 4 NA dead male NA
GSM734129 3 GSM437211 Y no; 1: metastasis): 0 1 19.03 POORLY DIFF Stage 3 8.58 dead female recurrence
GSM734128 3 NA N no; 1: metastasis): 0 1 85.93 MOD DIFF Stage 3 79.46 dead male recurrence
GSM734127 3 GSM437195 Y no; 1: metastasis): 0 2 59.07 MOD DIFF Stage 3 59.07 dead male no recurrence
GSM734126 3 GSM437191 Y no; 1: metastasis): 0 1 85.61 MOD DIFF Stage 3 85.61 alive female no recurrence
GSM734125 2 GSM437186 Y no; 1: metastasis): 0 2 20.44 MOD DIFF Stage 3 20.44 dead male no recurrence
GSM734124 3 GSM437184 N no; 1: metastasis): 0 1 6.11 POORLY DIFF Stage 3 5.35 dead male recurrence
GSM734123 3 GSM437196 Y no; 1: metastasis): 0 1 47.8 POORLY DIFF Stage 3 47.8 dead male no recurrence
GSM734122 3 GSM437175 Y no; 1: metastasis): 0 1 105.17 MOD DIFF Stage 3 105.17 alive male no recurrence
GSM73412 3 GSM437192 Y no; 1: metastasis): 0 1 78.87 MOD DIFF Stage 3 64.33 alive male no recurrence
GSM734120 3 GSM437151 Y no; 1: metastasis): 0 0 47.86 MOD DIFF Stage 2 47.86 alive male no recurrence
GSM734119 3 GSM437246 N no; 1: metastasis): 1 2 5.12 MOD DIFF Stage 4 NA dead female NA
GSM734118 3 GSM437265 Y no; 1: metastasis): 1 1 8.94 MOD DIFF Stage 4 8.94 dead male no recurrence
GSM734117 4 GSM437261 Y no; 1: metastasis): 1 0 42.27 MOD DIFF Stage 4 13.08 alive male recurrence
GSM734116 3 GSM437205 Y no; 1: metastasis): 0 1 38.72 MOD DIFF Stage 3 38.72 dead female no recurrence
GSM734115 3 GSM437266 Y no; 1: metastasis): 1 2 32.67 POORLY DIFF Stage 4 17.32 alive female recurrence
GSM734114 3 GSM437209 Y no; 1: metastasis): 0 1 59.34 POORLY DIFF Stage 3 59.34 alive male no recurrence
GSM734113 3 GSM437199 Y no; 1: metastasis): 0 1 74.07 MOD DIFF Stage 3 24.85 alive male recurrence
GSM734112 3 GSM437206 N no; 1: metastasis): 0 1 54.9 MOD DIFF Stage 3 54.9 dead female no recurrence
GSM734 3 GSM437213 Y no; 1: metastasis): 0 1 52.86 POORLY DIFF Stage 3 52.86 alive male no recurrence

Tags

  • cancer
  • colon
  • colon cancer

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use